KRas-IN-1

CAS No. 84783-01-7

KRas-IN-1( MDK-3017 | MDK3017 | MDK 3017 | K-Ras-IN-2 | K-Ras Inhibitor-2 )

Catalog No. M16153 CAS No. 84783-01-7

A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 140 In Stock
5MG 237 In Stock
10MG 357 In Stock
25MG 597 In Stock
50MG 851 In Stock
100MG 1152 In Stock
500MG 2313 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KRas-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.
  • Description
    A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM; binds to K-Ras in a hydrophobic pocket that is occupied by Tyr-71 in the apo-Ras crystal structure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDK-3017 | MDK3017 | MDK 3017 | K-Ras-IN-2 | K-Ras Inhibitor-2
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    84783-01-7
  • Formula Weight
    207.292
  • Molecular Formula
    C11H13NOS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 28 mg/mL
  • SMILES
    S=C(C1=CC=CC=C1O)N2CCCC2
  • Chemical Name
    Methanethione, (2-hydroxyphenyl)-1-pyrrolidinyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sun Q, et al. Angew Chem Int Ed Engl. 2012 Jun 18;51(25):6140-3.
molnova catalog
related products
  • AMG-510

    Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state.

  • J-104871

    J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.

  • 1588-A4

    1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.